IL131614A0 - Process for preparing trovafloxacin acid salts - Google Patents

Process for preparing trovafloxacin acid salts

Info

Publication number
IL131614A0
IL131614A0 IL13161499A IL13161499A IL131614A0 IL 131614 A0 IL131614 A0 IL 131614A0 IL 13161499 A IL13161499 A IL 13161499A IL 13161499 A IL13161499 A IL 13161499A IL 131614 A0 IL131614 A0 IL 131614A0
Authority
IL
Israel
Prior art keywords
acid salts
preparing
trovafloxacin acid
preparing trovafloxacin
salts
Prior art date
Application number
IL13161499A
Other languages
English (en)
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of IL131614A0 publication Critical patent/IL131614A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/52Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Indole Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Peptides Or Proteins (AREA)
IL13161499A 1998-09-03 1999-08-26 Process for preparing trovafloxacin acid salts IL131614A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US9894498P 1998-09-03 1998-09-03

Publications (1)

Publication Number Publication Date
IL131614A0 true IL131614A0 (en) 2001-01-28

Family

ID=22271674

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13161499A IL131614A0 (en) 1998-09-03 1999-08-26 Process for preparing trovafloxacin acid salts

Country Status (40)

Country Link
US (1) US6359137B1 (xx)
EP (1) EP0989119A1 (xx)
JP (1) JP3354526B2 (xx)
KR (1) KR20000022858A (xx)
CN (1) CN1248580A (xx)
AP (1) AP1118A (xx)
AR (1) AR021475A1 (xx)
AU (1) AU761035B2 (xx)
BG (1) BG103703A (xx)
BR (1) BR9904082A (xx)
CA (1) CA2281244C (xx)
CO (1) CO5251466A1 (xx)
EA (1) EA002340B1 (xx)
EE (1) EE04118B1 (xx)
GE (1) GEP20022785B (xx)
GT (1) GT199900142A (xx)
HN (1) HN1999000141A (xx)
HR (1) HRP990274A2 (xx)
HU (1) HUP9902967A3 (xx)
ID (1) ID23718A (xx)
IL (1) IL131614A0 (xx)
IN (1) IN191583B (xx)
IS (1) IS5168A (xx)
MA (1) MA24966A1 (xx)
MY (1) MY130800A (xx)
NO (1) NO994261L (xx)
NZ (1) NZ337605A (xx)
OA (1) OA11152A (xx)
PA (1) PA8481001A1 (xx)
PE (1) PE20001026A1 (xx)
PL (1) PL335246A1 (xx)
SG (1) SG74748A1 (xx)
SK (1) SK116599A3 (xx)
SV (1) SV1999000144A (xx)
TN (1) TNSN99164A1 (xx)
TR (1) TR199902138A2 (xx)
TW (1) TW520369B (xx)
UY (1) UY25686A1 (xx)
YU (1) YU43199A (xx)
ZA (1) ZA995630B (xx)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104892507B (zh) * 2015-05-26 2018-08-28 徐州天意动物药业股份有限公司 水溶性甲磺酸沙拉沙星及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5164402A (en) * 1989-08-16 1992-11-17 Pfizer Inc Azabicyclo quinolone and naphthyridinone carboxylic acids
WO1995019361A1 (en) * 1994-01-18 1995-07-20 Pfizer Inc. Process and intermediates for preparing naphthyridonecarboxylic acid salts
EP0789697B1 (en) * 1995-06-06 1998-06-17 Pfizer Inc. CRYSTAL FORM OF ANHYDROUS 7-((1a,5a, 6a)-6-AMINO-3-AZABICYCLO ( 3.1. 0]HEX-3-YL)-6-FLUORO-1-(2,4-DIFLUOROPHENYL)-1,4-DIHYDRO-4-OXO-1,8-NAPHTHYRIDINE-3-CARBOXYLIC ACID, METHANESULFONIC ACID SALT
JPH0912547A (ja) * 1995-06-23 1997-01-14 Chisso Corp ニューキノロン系化合物中間体の製造方法
JPH0912546A (ja) * 1995-06-23 1997-01-14 Chisso Corp アザビシクロ環化合物および製造方法
WO1997007800A1 (en) * 1995-08-29 1997-03-06 Pfizer Inc. Zwitterionic forms of trovafloxacin
PA8464701A1 (es) * 1998-01-16 2000-09-29 Pfizer Prod Inc Procedimiento e intermedios para preparar naftiridonas
US6184380B1 (en) * 1999-01-25 2001-02-06 Pfizer Inc. Process for preparing naphthyridones and intermediates

Also Published As

Publication number Publication date
SG74748A1 (en) 2000-08-22
AP9901667A0 (en) 1999-12-31
CN1248580A (zh) 2000-03-29
NZ337605A (en) 2001-03-30
EA199900708A3 (ru) 2000-08-28
AP1118A (en) 2002-11-21
HUP9902967A2 (hu) 2000-05-28
MA24966A1 (fr) 2000-04-01
BR9904082A (pt) 2000-09-12
PE20001026A1 (es) 2000-10-11
ID23718A (id) 2000-05-11
MY130800A (en) 2007-07-31
AR021475A1 (es) 2002-07-24
AU761035B2 (en) 2003-05-29
EP0989119A1 (en) 2000-03-29
PL335246A1 (en) 2000-03-13
US6359137B1 (en) 2002-03-19
JP3354526B2 (ja) 2002-12-09
EA002340B1 (ru) 2002-04-25
HRP990274A2 (en) 2000-10-31
UY25686A1 (es) 2000-03-31
BG103703A (bg) 2001-08-31
CO5251466A1 (es) 2003-02-28
TW520369B (en) 2003-02-11
KR20000022858A (ko) 2000-04-25
OA11152A (en) 2003-04-17
SK116599A3 (en) 2000-05-16
ZA995630B (en) 2001-03-01
NO994261D0 (no) 1999-09-02
TR199902138A2 (xx) 2000-04-21
IS5168A (is) 2000-03-04
GT199900142A (es) 2001-02-15
EE9900457A (et) 2000-04-17
TNSN99164A1 (fr) 2005-11-10
SV1999000144A (es) 2000-09-05
CA2281244C (en) 2003-05-20
NO994261L (no) 2000-03-06
AU4482699A (en) 2000-03-16
HU9902967D0 (en) 1999-10-28
CA2281244A1 (en) 2000-03-03
IN191583B (xx) 2003-12-06
PA8481001A1 (es) 2000-09-29
GEP20022785B (en) 2002-09-25
HUP9902967A3 (en) 2000-11-28
EE04118B1 (et) 2003-08-15
YU43199A (sh) 2002-11-15
HN1999000141A (es) 2000-06-19
EA199900708A2 (ru) 2000-04-24
JP2000086658A (ja) 2000-03-28

Similar Documents

Publication Publication Date Title
HUP0200402A3 (en) An improved process for the preparation of non-hygroscopic salts of l(-)-carnitine
IL150542A0 (en) Method for preparing hydroxypicolinic acid derivatives
IL126264A0 (en) Process for preparing lactic acid
HUP0103659A3 (en) Process for producing 6-cyanomethyl-1,3-dioxane-4-acetic acid derivatives
MXPA01013104A (es) Metodo para producir sales de esteres alcaloides acidos sulfograsos.
AU2001227086A1 (en) Process for preparing 2-hydroxy-4-methylthiobutanoic acid
IL131644A0 (en) Process for the preparation of nicotinic acid
HUP0202196A2 (en) Process for producing 4-amino-1-hidroxybutylidene-1,1-bisphosphonic acid and its trihydrrated monosodic salt
IL148330A0 (en) Process for preparing phenylacetic acid derivatives
HUP0102124A3 (en) Process for preparing 2-acetylthio-3-phenyl-propionic acid and the salts thereof
HUP0200342A2 (en) Novel process for preparing alendronic acid
HUP0201418A3 (en) Process for preparing r-(-)-carnitine from s-(-)-chlorosuccinic acid or from a derative thereof
HUP0100253A3 (en) Process for preparing (r)-2-bromo-3-phenyl-propionic acid
HUP9901041A3 (en) Process for preparing hydroxamic acid derivatives
SG71899A1 (en) Method for making bis-xylenols containing acid moieties
HUP0004619A3 (en) Method for preparing formylphosphonic acid
HU9902967D0 (en) Process for preparing trovafloxacin acid salts
IL148442A0 (en) Process for preparing methylene bisphosphonic acid and salts
HUP9900755A1 (en) Process for preparing propionic acid derivatives
AU6495298A (en) Process for preparing 3-hydroxy-3-methylbutyric acid or its salts
IL134912A0 (en) Method for preparing 1-phenylpyrrazolin-3-carboxylic acid derivatives
HK1027109A1 (en) Process for preparing 3-(7-amidino-2-naphthyl)-2-phenylpropionic acid derivatives.
EG21405A (en) Method for preparing phosphorique acid
SI1169326T1 (en) Process for preparing alendronic acid
ZA983777B (en) Method for preparing formylphosphonic acid